SEATTLE, Jan. 10 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX)
fourth quarter and full year financial results will be released as scheduled
on January 24, 2001 at market close. The company will also host a live
webcast at 2:00 p.m. PST (5:00 p.m. EST), following the announcement. Immunex
management will discuss earnings and other business results.
The live webcast can be accessed by going to the Immunex website at
http://www.immunex.com/investor/in10.html . Following the webcast, an
archived version of the call will be available at the same address until
January 31, 2001.
This press release is available on the Immunex website at
http://www.immunex.com , or on PRNewswire's website at
http://www.prnewswire.com .
Immunex Corporation is a leading biopharmaceutical company dedicated to
improving lives through immune system science innovations.
NOTE: This news release contains forward-looking statements that involve
risks and uncertainties, including risks associated with clinical development,
regulatory approvals, our reliance on third-party manufacturers, product
commercialization and other risks described from time to time in the SEC
reports filed by Immunex, including the most recently filed Form 10-Q. An
electronic version of this news release -- as well as additional information
about Immunex of interest to investors, customers, future employees and
patients -- is available on the Immunex home page at http://www.immunex.com.
SOURCE Immunex Corporation
 back to top
Related links:
http://www.immunex.com
Company News On-Call:
http://www.prnewswire.com/comp/434644.html or fax,
800-758-5804, ext. 434644
CONTACT:
media, Kris Greco, 206-470-4871, or
investors, Mark Leahy, 206-389-4363, both of Immunex Corporation
|
